首页> 外文期刊>Journal of chemical neuroanatomy >Induced pluripotent stem cells (iPSC)-derived retinal cells in disease modeling and regenerative medicine
【24h】

Induced pluripotent stem cells (iPSC)-derived retinal cells in disease modeling and regenerative medicine

机译:诱导多能干细胞(IPSC)在疾病建模和再生医学中的视网膜细胞

获取原文
获取原文并翻译 | 示例
           

摘要

Retinal degenerative disorders are a leading cause of the inherited, irreversible and incurable vision loss. While various rodent model systems have provided crucial information in this direction, lack of disease-relevant tissue availability and species-specific differences have proven to be a major roadblock. Human induced pluripotent stem cells (iPSC) have opened up a whole new avenue of possibilities not just in understanding the disease mechanism but also potential therapeutic approaches towards a cure. In this review, we have summarized recent advances in the methods of deriving retinal cell types from iPSCs which can serve as a renewable source of disease-relevant cell population for basic as well as translational studies. We also provide an overview of the ongoing efforts towards developing a suitable in vitro model for modeling retinal degenerative diseases. This basic understanding in turn has contributed to advances in translational goals such as drug screening and cell replacement therapies. Furthermore we discuss gene editing approaches for autologous repair of genetic disorders and allogeneic transplantation of stem cell-based retinal derivatives for degenerative disorders with an ultimate goal to restore vision. It is pertinent to note however, that these exciting new developments throw up several challenges that need to be overcome before their full clinical potential can be realized.
机译:视网膜退行性障碍是遗传,不可逆和可治区丧失的主要原因。虽然各种啮齿动物模型系统在此方向上提供了重要信息,但缺乏疾病相关的组织可用性和物种特异性差异已被证明是一个主要的障碍。人类诱导多能干细胞(IPSC)已经开辟了全新的可能性,而不仅仅是理解疾病机制,而且还对治疗方法的潜在治疗方法。在本综述中,我们总结了从IPSC衍生视网膜细胞类型的方法的最新进展,该方法可以作为基本和翻译研究的可再生性疾病相关细胞群。我们还概述了开发适用于造型视网膜退行性疾病的适当体外模型的努力。这种基本的理解又导致了诸如药物筛选和细胞替代疗法等翻译目标的进步。此外,我们讨论基因编辑遗传修复遗传紊乱和异种移植的干细胞基视网膜衍生物的异质移植,以恢复视觉的最终目标。然而,它有关要注意的是,这些令人兴奋的新发展促进了在完全临床潜力可以实现之前需要克服的若干挑战。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号